Notably, the usefulness of CCL28 as an adjuvant for mucosal vaccination was confirmed by recent data showing that the association of CCL28 and a DNA-based vaccine results in the generation of a potent immune response that prevents mucosally transmitted viral infections [22]. Here, CCL28 is linked to viral infectious disease.